| Product NDC: | 21695-259 |
| Proprietary Name: | Ciprofloxacin Hydrochloride |
| Non Proprietary Name: | ciprofloxacin hydrochloride |
| Active Ingredient(s): | 3.5 mg/mL & nbsp; ciprofloxacin hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-259 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019992 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19901231 |
| Package NDC: | 21695-259-25 |
| Package Description: | 2.5 mL in 1 BOTTLE, PLASTIC (21695-259-25) |
| NDC Code | 21695-259-25 |
| Proprietary Name | Ciprofloxacin Hydrochloride |
| Package Description | 2.5 mL in 1 BOTTLE, PLASTIC (21695-259-25) |
| Product NDC | 21695-259 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19901231 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
| Strength Number | 3.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |